COST EFFECTIVENESS OF PEGFILGRASTIM FOR REDUCING INCIDENCE OF FEBRILE NEUTROPENIA EVENTS AFTER CYTOTOXIC CHEMOTHERAPY FOR SOLID TUMORS IN TURKEY
dc.contributor.author | Malhan, Simtem | |
dc.contributor.author | Saka, G | |
dc.contributor.author | Villa, G. | |
dc.contributor.author | Worth, G. | |
dc.contributor.author | Barron, R. | |
dc.contributor.author | Lyman, G.H. | |
dc.date.accessioned | 2019-06-18T07:36:06Z | |
dc.date.available | 2019-06-18T07:36:06Z | |
dc.date.issued | 2016 | |
dc.identifier.issn | 1098-3015 | |
dc.identifier.uri | https://www.sciencedirect.com/science/article/pii/S109830151601665X?via%3Dihub | |
dc.identifier.uri | http://hdl.handle.net/11727/3583 | |
dc.language.iso | eng | en_US |
dc.relation.isversionof | 10.1016/j.jval.2016.03.1597 | en_US |
dc.rights | info:eu-repo/semantics/openAccess | en_US |
dc.title | COST EFFECTIVENESS OF PEGFILGRASTIM FOR REDUCING INCIDENCE OF FEBRILE NEUTROPENIA EVENTS AFTER CYTOTOXIC CHEMOTHERAPY FOR SOLID TUMORS IN TURKEY | en_US |
dc.type | conferenceObject | en_US |
dc.relation.journal | VALUE IN HEALTH | en_US |
dc.identifier.volume | 19 | en_US |
dc.identifier.issue | 3 | en_US |
dc.identifier.startpage | A151 | en_US |
dc.identifier.endpage | A151 | en_US |
dc.identifier.wos | 000394931000272 | en_US |